Immunodiagnosis of Tuberculosis

New Questions, New Tools

- Abstract submission deadline is July 1
- Travel award application deadline is July 1
- Conference registration remains open after July 1

The objective of the conference is to integrate knowledge generated through basic, translational and clinical research that can lead to novel methods and strategies for the immunodiagnosis of tuberculosis.

The conference brings together leaders in host and pathogen biology, epidemiology, diagnostic development and use, and in basic and clinical research to

  1. Discuss the most recent findings in the biology of the pathogen and of the host immune response that are most relevant to the identification of immune markers.
  2. Review the status of field studies and clinical trials that can be utilized for identification of immune biomarkers.
  3. Discuss cutting-edge technologies that can lead to development of assay formats amenable to use in diverse settings.
  4. Place particular attention to pediatric tuberculosis, which poses unique diagnostic challenges.

 

 

 

Organizers

Marila Gennaro, Public Health Research Institute, NJMS, Newark, NJ, USA

Mark Doherty, Statens Serum Institute, Copenhagen, Denmark

Presented under the auspices of the Stop TB Working Group on Diagnostics

 

 

Conference Sponsors

This conference is made possible by the generous support of our sponsors and donators.  Major support is provided by:

Visit our sponsors page »

 

 

Conference Summary

September 21 – September 23, 2008

The conference includes plenary sessions and poster sessions.

Plenary sessions:

  • Keynote lecture
    Mario Raviglione, Stop TB Department, World Health Organization, Geneva, Switzerland
  • Pathogen and host biology (I)
    chair: Douglas Young, Imperial College, London, England
  • Pathogen and host biology (II)
    chair: Stefan Kaufman, Max Planck Institute for Infectious Diseases, Berlin, Germany
  • Field studies/clinical trials
    chair: Dick Menzies, McGill University, Montreal, Quebec, Canada
  • Pediatric tuberculosis
    chair: Anneke Hesseling, Stellenbosch University, Cape Town, South Africa
  • New strategies for immunodiagnosis (I)
    chair: Mario Roederer, National Institutes of Health, Bethesda, Maryland, USA
  • New strategies for immunodiagnosis (II)
    chair: Philip Felgner, University of California, Irvine, CA, USA

The plenary sessions feature invited speakers, and speakers selected from among those submitting abstracts for poster presentation.

Click here for the complete conference schedule »

To encourage global participation, a limited number of junior travel awards will be available for junior investigators from developing countries. Support for junior travel awards is provided by the National Institute of Allergy and Infectious Disease.

The conference will be held at the Founder’s Inn & Spa, Virginia Beach, Virginia, USA, an all-inclusive conference site located less than 10 miles from Norfolk International Airport.  All costs, including on-site accommodation and meals for the duration of the conference are included in the registration package.